<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34210839</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1472-3263</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>98</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Sexually transmitted infections</Title>
          <ISOAbbreviation>Sex Transm Infect</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The clinical indications for testing women for <i>Mycoplasma genitalium</i>.</ArticleTitle>
        <Pagination>
          <StartPage>277</StartPage>
          <EndPage>285</EndPage>
          <MedlinePgn>277-285</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/sextrans-2020-054818</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">While the contribution of <i>Mycoplasma genitalium</i> (MG) to symptoms in men is well described, less is known about its association with common genital symptoms in women. We aimed to determine the prevalence of MG and macrolide resistance, and its association with common genital symptoms in women attending a sexual health service, to inform indications for testing and clinical practice.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We undertook a cross-sectional study of symptomatic and asymptomatic women attending Melbourne Sexual Health Centre (MSHC), between April 2017 and April 2019. Women were tested for MG and macrolide resistance, <i>Chlamydia trachomatis</i> (CT), <i>Neisseria gonorrhoeae</i>, <i>Trichomonas vaginalis</i>, bacterial vaginosis and vulvovaginal candidiasis. Women completed a questionnaire on symptoms, and symptomatic women underwent examination. The prevalence of MG (and macrolide resistance) and other genital infections was calculated with 95% CIs, and associations between these outcomes and specific genital symptoms were examined using logistic regression.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1318 women, 83 (6%, 95% CI: 5% to 8%) had MG, of which 39 (48%, 95% CI: 36% to 59%) had macrolide-resistant MG; 103 (8%, 95% CI: 6% to 9%) women had CT. MG prevalence was similar in asymptomatic (10 of 195; 5%) and symptomatic (73 of 1108; 7%) women, p=0.506. MG was associated with mucopurulent cervicitis on examination (adjusted OR=4.38, 95% CI: 1.69 to 11.33, p=0.002), but was not associated with other specific genital symptoms or signs.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">MG was as common as CT among women attending MSHC. MG was not associated with genital symptoms, but like CT, was significantly associated with cervicitis. These data provide evidence that routine testing for MG in women with common genital symptoms is not indicated. The presence of macrolide resistance in 48% of women supports use of resistance-guided therapy.</AbstractText>
          <CopyrightInformation>© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Latimer</LastName>
            <ForeName>Rosie L</ForeName>
            <Initials>RL</Initials>
            <Identifier Source="ORCID">0000-0003-0940-3722</Identifier>
            <AffiliationInfo>
              <Affiliation>Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia rosie.latimer@monash.edu.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Central Clinical School, Monash University, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vodstrcil</LastName>
            <ForeName>Lenka A</ForeName>
            <Initials>LA</Initials>
            <Identifier Source="ORCID">0000-0003-3679-9195</Identifier>
            <AffiliationInfo>
              <Affiliation>Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Central Clinical School, Monash University, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Plummer</LastName>
            <ForeName>Erica L</ForeName>
            <Initials>EL</Initials>
            <Identifier Source="ORCID">0000-0001-5710-2671</Identifier>
            <AffiliationInfo>
              <Affiliation>Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Central Clinical School, Monash University, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Doyle</LastName>
            <ForeName>Michelle</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Murray</LastName>
            <ForeName>Gerald L</ForeName>
            <Initials>GL</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Microbiology Research Group, Murdoch Children's Research institute, Parkville, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Women's Infectious Diseases, Royal Women's Hospital, Parkville, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fairley</LastName>
            <ForeName>Christopher K</ForeName>
            <Initials>CK</Initials>
            <Identifier Source="ORCID">0000-0001-9081-1664</Identifier>
            <AffiliationInfo>
              <Affiliation>Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Central Clinical School, Monash University, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bodiyabadu</LastName>
            <ForeName>Kaveesha</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Microbiology Research Group, Murdoch Children's Research institute, Parkville, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Women's Infectious Diseases, Royal Women's Hospital, Parkville, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>SpeeDx Pty Ltd, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Read</LastName>
            <ForeName>Tim R H</ForeName>
            <Initials>TRH</Initials>
            <AffiliationInfo>
              <Affiliation>Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Central Clinical School, Monash University, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaiser</LastName>
            <ForeName>Marti</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mokany</LastName>
            <ForeName>Elisa</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>SpeeDx Pty Ltd, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guy</LastName>
            <ForeName>Rebecca</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Sexual Health Program, The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chow</LastName>
            <ForeName>Eric P F</ForeName>
            <Initials>EPF</Initials>
            <Identifier Source="ORCID">0000-0003-1766-0657</Identifier>
            <AffiliationInfo>
              <Affiliation>Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Central Clinical School, Monash University, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bradshaw</LastName>
            <ForeName>Catriona</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Central Clinical School, Monash University, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>07</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Sex Transm Infect</MedlineTA>
        <NlmUniqueID>9805554</NlmUniqueID>
        <ISSNLinking>1368-4973</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018942">Macrolides</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002690" MajorTopicYN="Y">Chlamydia Infections</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002692" MajorTopicYN="N">Chlamydia trachomatis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024881" MajorTopicYN="N">Drug Resistance, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018942" MajorTopicYN="N">Macrolides</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009175" MajorTopicYN="Y">Mycoplasma Infections</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045704" MajorTopicYN="Y">Mycoplasma genitalium</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009344" MajorTopicYN="N">Neisseria gonorrhoeae</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002575" MajorTopicYN="Y">Uterine Cervicitis</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chlamydia Infections</Keyword>
        <Keyword MajorTopicYN="N">Female</Keyword>
        <Keyword MajorTopicYN="N">Genital Diseases</Keyword>
        <Keyword MajorTopicYN="N">Mycoplasma genitalium</Keyword>
        <Keyword MajorTopicYN="N">SEXUAL HEALTH</Keyword>
        <Keyword MajorTopicYN="N">Uterine Cervicitis</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: Melbourne Sexual Health Centre received funding from SpeeDx (Australia) in support of this research project. The remaining authors report no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>2</Day>
          <Hour>5</Hour>
          <Minute>52</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34210839</ArticleId>
        <ArticleId IdType="doi">10.1136/sextrans-2020-054818</ArticleId>
        <ArticleId IdType="pii">sextrans-2020-054818</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
